General Electric Analyst Consensus Estimates For Q1 2021

General Electric (NYSE: GE) will be reporting their first quarter financial results on April 27th before the market open. Analysts have a consensus $14.27 12-month price target on the company, via a total of 19 analysts, with five analysts having strong buy ratings. Seven analysts meanwhile have buy ratings and, seven have hold ratings. The street high comes from Langberg & Co with a $18 price target, and the lowest target sits at $5 from Cowen and Co.

16 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 16 analysts is $17.52 billion; this number has been revised downwards from $18.34 billion at the start of the year. The highest revenue estimate is $18.21 billion, while the lowest is $16.67 billion.

Onto EBITDA estimates, there are currently only 4 analysts who have first-quarter EBITDA estimates. The mean is currently $1.5 billion, with this number having been revised down from $1.76 billion at the start of the year. The street high estimate currently sits at $1.7 billion in EBITDA and the lowest is $1.34 billion.

Analysts estimate that quarterly earnings per share will come in at $0.01, with this number being slightly revised down from $0.04 at the start of the year. Street high is $0.04 and the lowest estimate is negative $0.01 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Canadian Copper Secures Key Approval for Caribou Complex Acquisition

Related News

Southwest Airlines: Analyst Consensus Estimates For Q1 2021

Southwest Airlines (NASDAQ: LUV) will be reporting their first quarter results on April 22nd before...

Tuesday, April 20, 2021, 11:49:00 AM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Canacol: BMO Reiterates Market Perform Rating Following 2022 Guidance

On December 15th, Canacol Energy Ltd. (TSX: CNE) provided its 2022 sales and capital guidance....

Monday, December 27, 2021, 03:05:00 PM

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM

BMO Cuts GoGold’s Price Target Due To Market Headwinds

On July 13, GoGold Resources (TSX: GGD) announced their second quarter production results. The company...

Friday, July 15, 2022, 11:51:00 AM